Titlebook: Contrast Harmonic Imaging in the Diagnosis and Treatment of Hepatic Tumors; Masatoshi Kudo Book 20031st edition Springer Japan 2003 carcin

只看該作者 · 發(fā)表于 2025-4-1 01:53:28

Comparative Pharmacokinetic Behavior of Levovist with Water-Soluble Contrast Agents,of water-soluble contrast agents. The enhancement patterns observed on computed tomography (CT), angiography, and dynamic magnetic resonance imaging (MRI) do not apply to contrast-enhanced ultrasonography (US) with Levovist. In a certain way, the behavior of Levovist is similar to that of water-solu

只看該作者 · 發(fā)表于 2025-4-1 08:41:33

只看該作者 · 發(fā)表于 2025-4-1 13:47:30

只看該作者 · 發(fā)表于 2025-4-1 18:01:42

只看該作者 · 發(fā)表于 2025-4-1 22:13:35

只看該作者 · 發(fā)表于 2025-4-2 00:33:32

只看該作者 · 發(fā)表于 2025-4-2 02:53:26

The Role of Contrast-Enhanced Ultrasonography in the Diagnosis and Treatment of Hepatic Tumors (Sumntial diagnosis, and application in the treatment of hepatic tumors. It must be remembered, however, that characterization of a hepatocellular carcinoma (HCC), a borderline lesion associated with hepatocellular carcinoma, and a nodular lesion associated with liver cirrhosis can only be made with the

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 09:02
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved